SAN FRANCISCO – Hospitalization rates for gout doubled between 1993 and 2011, while those for rheumatoid arthritis fell by 67%, Dr. Sian Yik Lim reported at the annual meeting of the American College...
SAN FRANCISCO – The anti-CD22 monoclonal antibody epratuzumab missed its primary and secondary endpoints in two phase III trials involving adults with moderate to severe systemic lupus...
SAN FRANCISCO – Mounting evidence supports the use of tocilizumab in giant cell arteritis (GCA), and a new study supports use of the drug for induction and maintenance therapy in patients with newly...
SAN FRANCISCO – Denosumab was superior to zoledronic acid (ZA) in building bone at the lumber spine, total hip, and femoral neck in postmenopausal women with osteoporosis previously treated with oral...
SAN FRANCISCO – Patients with gout who fail to sufficiently lower their serum urate level despite adherence to a regimen of allopurinol 300 mg/day may have a genetic polymorphism affecting their...
SAN FRANCISCO – Video capsule endoscopy proved superior to ileocolonoscopy in detecting lesions consistent with Crohn’s disease in patients with known spondyloarthropathies in a study presented at...
SAN FRANCISCO – Intra-articular ozone injections were effective in reducing pain, improving function, and improving quality of life in patients with knee osteoarthritis in the first randomized study...
SAN FRANCISCO – New classification criteria for Sjögren’s syndrome are ready for sign-off by the American College of Rheumatology and the European League Against Rheumatism, Dr. Caroline Shiboski...
SAN FRANCISCO – Two population-based studies provide encouraging evidence that mortality, particularly cardiovascular mortality, is declining in people with rheumatoid arthritis.
The first study –...
SAN FRANCISCO – Anakinra might be a life saver for recurrent idiopathic pericarditis when corticosteroids, colchicine, and NSAIDS aren’t working.
Anakinra (Kineret) seemed to end the cycle of...
